DBDiaSNP: An Open-Source Knowledgebase of Genetic Polymorphisms and Resistance Genes Related to Diarrheal Pathogens

Kusum Mehla1, Jayashree Ramana1

  • 1Department of Biotechnology and Bioinformatics, Jaypee University of Information Technology , Solan, Himachal Pradesh, India .

Insights

DBDiaSNP is a new database detailing mutations and antibiotic resistance genes in diarrheal pathogens. This resource aids in developing diagnostics and drugs for treating childhood diarrhea globally.

Area of Science:

  • Microbiology
  • Genetics
  • Bioinformatics

Background:

  • Diarrhea is a leading cause of childhood morbidity and mortality worldwide, with increasing antibiotic resistance complicating treatment.
  • Enteric pathogens harbor mutations and resistance genes that contribute to antibiotic resistance, necessitating global surveillance.
  • Single Nucleotide Polymorphisms (SNPs) offer potential for molecular diagnostics and pharmacogenomics in understanding genotype-phenotype links.

Purpose of the Study:

  • To introduce DBDiaSNP, a comprehensive, open-access database of mutations and resistance genes in diarrheal pathogens and hosts.
  • To facilitate research in developing sequence-based diagnostics and novel drug discovery for diarrheal diseases.
  • To support global health initiatives through enhanced monitoring and personalized treatment strategies.

Main Methods:

  • Compilation of mutation and resistance gene data from scientific literature and web resources.
  • Inclusion of data on pathogens such as Diarrheagenic E.coli (DEC), Salmonella spp., and Vibrio cholera.
  • Incorporation of host genetic variations influencing susceptibility or resistance to diarrhea.

Main Results:

  • DBDiaSNP contains information on 946 mutations and 326 resistance genes as of March 2015.
  • The database covers a wide range of diarrheal pathogens, including bacterial, viral, and parasitic agents.
  • It integrates data on both pathogen-specific resistance mechanisms and host genetic factors.

Conclusions:

  • DBDiaSNP is a valuable, integrated resource for researchers and clinicians studying diarrheal diseases.
  • It represents one of the first databases to cover antibiotic resistance in diarrheal pathogens comprehensively, including mutations and host factors.
  • The database holds significant potential for translational research, global health, and personalized medicine in combating diarrheal diseases.

Related Concept Videos

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
126
Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
113
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
2.0K
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
69
Pharmacogenetics of Drug Metabolism: Overview01:27

Pharmacogenetics of Drug Metabolism: Overview

Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
150
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters01:16

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
150